AIP.NASDAQArteris, INC

Form 4: Arteris VP Sells Shares for Tax & 10b5-1 Plan

Sentiment:

Insider Transaction Report


Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, reported the sale of 683 shares of common stock for tax obligations and under a pre-arranged 10b5-1 trading plan.

Summary

  • Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), reported two sales of common stock.
  • On December 2, 2025, 258 shares were sold at $14.8246 per share to cover tax liabilities arising from the release of restricted stock units.
  • On December 3, 2025, an additional 425 shares were sold at $14.79 per share, executed under a Rule 10b5-1 trading plan adopted on June 5, 2025.
  • Following these transactions, Alpern beneficially owns 65,277 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of insider stock sales for tax purposes and under a pre-arranged 10b5-1 plan, which are common and generally not indicative of significant positive or negative company-specific news.

Positives

  • The transaction on December 3, 2025, was executed under a Rule 10b5-1 trading plan, indicating pre-planned sales and reducing concerns about opportunistic insider trading.
  • The sale on December 2, 2025, was explicitly for tax liability, a common and routine reason for insider sales.

Negatives

  • Insider selling, even for routine reasons, can sometimes be perceived negatively by the market, though the amounts here are relatively small.

Future Outlook

NA

Management Comments

  • Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
  • Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 5, 2025.

Industry Context

This is a routine insider transaction filing and does not provide specific industry context. Such sales are common for executives managing personal finances and tax obligations.

Stakeholder Impact

  • Shareholders: The sale represents a minor reduction in insider ownership, but the stated reasons (tax liability, 10b5-1 plan) suggest it is not a signal of a lack of confidence in the company.
  • Employees, Customers, Suppliers, Creditors: No direct impact from this routine insider transaction.

Key Dates

DateDescription
06/05/2025Date the Reporting Person adopted the 10b5-1 trading plan.
12/02/2025Transaction date for the sale of 258 shares to satisfy tax liability.
12/03/2025Transaction date for the sale of 425 shares under a 10b5-1 plan.
12/04/2025Date the Form 4 was signed and filed.

Keywords

Arteris, AIP, Insider Trading, Form 4, Stock Sale, Paul Alpern, 10b5-1 Plan, Restricted Stock Units, Corporate Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.